:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UMBPQVZNEBHIVGQP7NPKNZNMGM.jpeg)
Amicus Therapeutics, Inc., a global biotechnology company based in Princeton, N.J., announced on May 8, 2024, that its management team will be participating in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV. The session is scheduled for Wednesday, May 15, 2024, at 1:40 p.m. P.T. Interested viewers can access a live audio webcast of the presentation through the investors section of the Amicus Therapeutics corporate website at
Amicus Therapeutics is listed on Nasdaq under the symbol FOLD and is focused on discovering, developing and delivering high-quality medicines for individuals with rare diseases. The company’s mission is to advance and expand a pipeline of innovative medicines for rare diseases with a strong emphasis on meeting the needs of patients. To learn more about Amicus Therapeutics and its work, visit the company’s website at
For investor inquiries, please contact Andrew Faughnan, Vice President of Investor Relations, at [afaughnan@amicusrx.com](mailto:afaughnan@amicusrx.com) or (609) 662-3809. For media inquiries, reach out to Diana Moore, Head of Global Corporate Affairs and Communications at [dmoore@amicusrx
